THE ROLE OF ARTIFICIAL INTELLIGENCE IN PATHOLOGIC DIAGNOSIS

IF 3.3 4区 医学 Q2 HEMATOLOGY
P. Brousset
{"title":"THE ROLE OF ARTIFICIAL INTELLIGENCE IN PATHOLOGIC DIAGNOSIS","authors":"P. Brousset","doi":"10.1002/hon.70093_8","DOIUrl":null,"url":null,"abstract":"<p>Over the last ten years, there have been thousands of papers describing the potential role of artificial intelligence (AI) algorithms in medical decision making. The impact of AI breakthroughs seems to be major in the field of medical image analysis in which such algos are supposed to do a better job than medical doctors, especially in radiology. Although the use of AI in medicine will increase over time, today the use of AI algos in medical decision assistance is quite limited. Radiology images are directly obtained from a machine whereas histopathology images are converted (digitized) from colored tissue sections on glass slides. The latter represent a tremendous source of heterogeneity explained by inter laboratory variations of tissue section processing. So far, most of the algos proposing automatic analysis of histopathology images are based on convolutional neural networks (CNN) which are extremely sensitive to variations of image heterogeneity and thus prone to overfitting. In other words, an algo trained on pictures produced in lab A is unable to recognize the same pictures obtained from lab B. In this presentation, different alternatives to circumvent CNN (deep learning) limitations will be presented. One of the strategy is to use large scale AI models so called foundation models (FM) based on transformer architectures which are trained on huge amounts of pictures. Another approach, less costly in terms of data input for training, is to use cartesian genetic programming (CGP) algos which, in addition, fill the gap of explainability of decision making. The final goal is to come out with AI solutions proposing a robust (accurate) assistance in picture analysis that can be run in every pathology laboratory regardless of tissue processing variations.</p><p><b>Keywords:</b> bioinformatics; computational and systems biology; pathology and classification of lymphomas</p><p>No potential sources of conflict of interest.</p>","PeriodicalId":12882,"journal":{"name":"Hematological Oncology","volume":"43 S3","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.70093_8","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematological Oncology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hon.70093_8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Over the last ten years, there have been thousands of papers describing the potential role of artificial intelligence (AI) algorithms in medical decision making. The impact of AI breakthroughs seems to be major in the field of medical image analysis in which such algos are supposed to do a better job than medical doctors, especially in radiology. Although the use of AI in medicine will increase over time, today the use of AI algos in medical decision assistance is quite limited. Radiology images are directly obtained from a machine whereas histopathology images are converted (digitized) from colored tissue sections on glass slides. The latter represent a tremendous source of heterogeneity explained by inter laboratory variations of tissue section processing. So far, most of the algos proposing automatic analysis of histopathology images are based on convolutional neural networks (CNN) which are extremely sensitive to variations of image heterogeneity and thus prone to overfitting. In other words, an algo trained on pictures produced in lab A is unable to recognize the same pictures obtained from lab B. In this presentation, different alternatives to circumvent CNN (deep learning) limitations will be presented. One of the strategy is to use large scale AI models so called foundation models (FM) based on transformer architectures which are trained on huge amounts of pictures. Another approach, less costly in terms of data input for training, is to use cartesian genetic programming (CGP) algos which, in addition, fill the gap of explainability of decision making. The final goal is to come out with AI solutions proposing a robust (accurate) assistance in picture analysis that can be run in every pathology laboratory regardless of tissue processing variations.

Keywords: bioinformatics; computational and systems biology; pathology and classification of lymphomas

No potential sources of conflict of interest.

人工智能在病理诊断中的作用
在过去的十年里,已经有成千上万的论文描述了人工智能(AI)算法在医疗决策中的潜在作用。人工智能的突破似乎在医学图像分析领域产生了重大影响,在这个领域,人工智能算法应该比医生做得更好,尤其是在放射学领域。尽管人工智能在医学中的应用将随着时间的推移而增加,但目前人工智能算法在医疗决策辅助方面的应用相当有限。放射学图像是直接从机器获得的,而组织病理学图像是由玻璃片上的彩色组织切片转换(数字化)的。后者代表了组织切片处理的实验室间差异所解释的异质性的巨大来源。目前提出的组织病理学图像自动分析算法大多基于卷积神经网络(CNN),该算法对图像异质性的变化极为敏感,容易出现过拟合。换句话说,在实验室A中生成的图像上训练的算法无法识别从实验室b中获得的相同图像。在本次演讲中,将提出不同的替代方案来绕过CNN(深度学习)的限制。其中一种策略是使用大规模的人工智能模型,即基于变压器架构的基础模型(FM),这些模型是在大量图片上进行训练的。另一种在训练数据输入方面成本较低的方法是使用笛卡尔遗传规划(CGP)算法,该算法还填补了决策可解释性的空白。最终目标是提出人工智能解决方案,在图像分析方面提供强大(准确)的帮助,可以在每个病理实验室运行,无论组织处理变化如何。关键词:生物信息学;计算与系统生物学;无潜在的利益冲突来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hematological Oncology
Hematological Oncology 医学-血液学
CiteScore
4.20
自引率
6.10%
发文量
147
审稿时长
>12 weeks
期刊介绍: Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged: -Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders -Diagnostic investigations, including imaging and laboratory assays -Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases -Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies -Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems. Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信